Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

China · Delayed Price · Currency is CNY

21.30

-0.21 (-0.98%)

Sep 24, 2026, 3:04 PM CST

Market Cap	7.35B -16.5%
Revenue (ttm)	3.30B +4.9%
Net Income	90.54M -41.9%
EPS	0.27 -40.8%
Shares Out	345.02M
PE Ratio	79.98
Forward PE	23.41
Dividend	0.05 (0.23%)
Ex-Dividend Date	Jun 2, 2026

Volume	2,066,960
Open	21.51
Previous Close	21.51
Day's Range	21.28 - 21.83
52-Week Range	17.98 - 27.80
Beta	0.25
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 26, 2026

About SHE:300702

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of anti-hypertensive, anti-allergic, anticancer, anti-fungal, anti-epileptic, anti-asthmatic, hypoglycemic, hypolipidemic, and anticoagulant series. It also provides fine chemicals and CDMO services. The company was founded in 1993 and is headquartered in Taizhou, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1993

Employees 4,686

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300702

Full Company Profile

Financial Performance

In 2025, SHE:300702's revenue was 3.06 billion, an increase of 16.36% compared to the previous year's 2.63 billion. Earnings were 139.71 million, an increase of 149.78%.

Financial Statements